[1]魏谭伟.先天性无虹膜症PAX6致病基因分析及其分子诊断研究[J].医学信息,2022,35(10):78-82.[doi:10.3969/j.issn.1006-1959.2022.10.019]
 WEI Tan-wei.A PAX6 Pathogenic Gene Analysis and Molecular Diagnosis of Congenital Aniridia[J].Medical Information,2022,35(10):78-82.[doi:10.3969/j.issn.1006-1959.2022.10.019]
点击复制

先天性无虹膜症PAX6致病基因分析及其分子诊断研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年10期
页码:
78-82
栏目:
综述
出版日期:
2022-05-15

文章信息/Info

Title:
A PAX6 Pathogenic Gene Analysis and Molecular Diagnosis of Congenital Aniridia
文章编号:
1006-1959(2022)10-0078-05
作者:
魏谭伟
(武汉市普仁医院眼科,湖北 武汉 430081)
Author(s):
WEI Tan-wei
(Department of Ophthalmology,Wuhan Puren Hospital,Wuhan 430081,Hubei,China)
关键词:
先天性无虹膜症PAX6基因分子诊断基因突变
Keywords:
Congenital aniridiaPAX6Molecular diagnosisGene mutation
分类号:
R773.1
DOI:
10.3969/j.issn.1006-1959.2022.10.019
文献标志码:
A
摘要:
先天性无虹膜症是一种眼部虹膜组织高度发育不良导致视功能严重异常的遗传病,其发病机制非常复杂,主要与调控虹膜发育的基因表达有关,其中最重要的调控基因是人类配对盒基因6(PAX6)。在眼部发育过程,PAX6由于各种原因发生基因突变导致表达异常,引起虹膜组织先天发育不良,导致无虹膜症的发生,严重影响人类视觉功能。随着分子生物学技术的发展,对于先天性无虹膜症致病基因PAX6的研究有很大的进展,本文对先天性无虹膜症的主要致病基因PAX6基因及其分子诊断方法作一综述,以期为先天性无虹膜症的基因靶向治疗提供理论基础。
Abstract:
Congenital aniridia is a genetic disease with highly dysplasia of the iris tissue leading to severe abnormal visual function. The pathogenesis of congenital aniridia is very complex, mainly related to the expression of genes regulating iris development, among which the most important regulation gene is PAX6 gene. In the process of eye development, PAX6 gene mutation leads to abnormal expression due to various reasons, resulting in congenital dysplasia of iris tissue, which seriously affects human visual function. With the development of molecular biology technology, great progress has been made in the study of the pathogenic gene PAX6 of congenital aniridia. This paper reviews the main pathogenic gene PAX6 and its molecular diagnosis methods, providing a theoretical basis for gene targeted therapy of congenital aniridia.

参考文献/References:

[1]丛日昌,韩丽川,宋书娟.PAX6基因突变至先天性无虹膜一家系的临床相关性研究[J].眼科新进展,2008(11):829-831,849.[2]张陆希.中国一先天性无虹膜家系基因突变位点的测序及遗传分析[D].郑州:郑州大学,2017.[3]Luo F,Zhou L,Ma X,et al.Mutation analysis of PAX6 in a Chinese family and a patient with a presumed sporadic case of congenital aniridia[J].Ophthalmic Res,2012,47(1):27-31.[4]Cao X,Zhou XM,Gan R,et al.A novel mutation of PAX6 identified in a Chinese twin family with congenital aniridia complicated with nystagmus[J].Genet Mol Res,2014,13(4):8679-8685.[5]Zhang R,Linpeng S,Wei X,et al.Novel variants in PAX6 gene caused congenital aniridia in two Chinese families[J].Eye (Lond),2017,31(6):956-961.[6]Lin Y,Gao H,Zhu Y,et al.Two Paired Box 6 mutations identified in Chinese patients with classic congenital aniridia and cataract[J].Mol Med Rep,2018,18(5):4439-4445.[7]Zhuang J,Chen X,Tan Z,et al.A novel de novo duplication mutation of PAX6 in a Chinese family with aniridia and other ocular abnormalities[J].Sci Rep,2014(4):4836.[8]Ying M,Han R,Hao P,et al.Inherited KIF21A and PAX6 gene mutations in a boy with congenital fibrosis of extraocular muscles and aniridia[J].BMC Med Genet,2013(14):63.[9]Qiu JJ,Zhang Q,Geng ZX,et al.Identification of a novel PAX6 mutation in a Chinese family with aniridia[J].BMC Ophthalmol,2019,19(1):10.[10]Wawrocka A,Budny B,Debicki S,et al.PAX6 3’ deletion in a family with aniridia[J].Ophthalmic Genet,2012,33(1):44-48.[11]Sonoda S,Isashiki Y,Tabata Y,et al.A novel PAX6 gene mutation (P118R) in a family with congenital nystagmus associated with a variant form of aniridia[J].Graefes Arch Clin Exp Ophthalmol,2000,238(7):552-558.[12]Goswami S,Gupta V,Srivastava A,et al.A novel duplication in the PAX6 gene in a North Indian family with aniridia[J].Int Ophthalmol,2014,34(6):1183-1188.[13]Bai Z,Kong X.Extension of the mutation spectrum of PAX6 from three Chinese congenital aniridia families and identification of male gonadal mosaicism[J].Mol Genet Genomic Med,2018,6(6):1053-1067.[14]Pérez-Solórzano S,Chacón-Camacho OF,AstiazaránMC,et al.PAX6 allelic heterogeneity in Mexican congenital aniridia patients: expanding the mutational spectrum with seven novel pathogenic variants[J].Clin Exp Ophthalmol,2017,45(9):875-883.[15]Lin Y,Gao H,Zhu Y,et al.Two Paired Box 6 mutations identified in Chinese patients with classic congenital aniridia and cataract[J].Mol Med Rep,2018,18(5):4439-4445. [16]Park SH,Kim MS,Chae H,et al.Molecular analysis of the PAX6 gene for congenital aniridia in the Korean population: identification of four novel mutations[J].Mol Vis,2012(18):488-494.[17]Sale MM,Craig JE,Charlesworth JC,et al.Broad phenotypic variability in a single pedigree with a novel 1410delC mutation in the PST domain of the PAX6 gene[J].Hum Mutat,2002,20(4):322.[18]张钏,郝胜菊,张庆华,等.PAX6基因新突变导致先天性无虹膜一例[J].中华医学遗传学杂志,2019,36(6):616-619.[19]陈靖,朱思泉.先天性无虹膜合并先天性白内障家系致病基因突变分析[J].国际眼科杂志,2019,19(8):1396-1399.[20]Cai F,Zhu J,Chen W,et al.A novel PAX6 mutation in a large Chinese family with aniridia and congenital cataract[J].Mol Vis,2010(16):1141-1145.[21]Han KH,Lee HJ,Ha IS,et al.A nonsense PAX6 mutation in a family with congenital aniridia[J].Korean J Pediatr,2016,59(Suppl 1):S1-S4.[22]Giray Bozkaya O,Ataman E,Aksel Kilicarslan O,et al.Identification of a novel frameshift heterozygous deletion in exon8 of the PAX6 gene in a pedigree with aniridia[J].Mol Med Rep,2016,14(3):2150-2154.[23]Liu Q,Wan W,Liu Y,et al.A novel PAX6 deletion in a Chinese family with congenital aniridia[J].Gene,2015,563(1):41-44.[24]Zhang X,Tong Y,Xu W.et al.Two novel mutations of the PAX6 gene causing different phenotype in a cohort of Chinese patients[J].Eye (Lond),2011,25(12):1581-1589.[25]Shukla S,Mishra R.Predictions on impact of missense mutations on structure function relationship of PAX6 and its alternatively spliced isoform PAX6(5a)[J].Interdiscip Sci,2012,4(1):54-73.[26]Zhang X,Qin G,Chen G,et al.Variants in TRIM44 Cause Aniridia by Impairing PAX6 Expression[J].Hum Mutat,2015,36(12):1164-1167.[27]Chen JH,Lin W,Sun G,et al.A novel PAX6 deletion in a Chinese family with congenital aniridia[J].Mol Vis,2012(18):989-995.[28]Jin C,Wang Q,Li J,et al.A recurrent PAX6 mutation is associated with aniridia and congenital progressive cataract in a Chinese family[J].Mol Vis,2012(18):465-470.[29]Chao LY,Mishra R,Strong LC,et al.Missense mutations in the DNA-binding region and termination codon in PAX6[J].Hum Mutat,2003,21(2):138-145.[30]Liu X,Wu Y,Miao Z,et al.A novel deletion downstream of the PAX6 gene identified in a Chinese family with congenital aniridia[J].Ophthalmic Genet,2018,39(4):428-436.[31]He F,Liu DL,Chen MP,et al.A rare PAX6 mutation in a Chinese family with congenital aniridia[J].Genet Mol Res,2015,14(4):13328-13336.[32]Beby F,Dieterich K,Calvas P.A [c.566-2A>G] heterozygous mutation in the PAX6 gene causes aniridia with mild visual impairment[J].Eye (Lond),2011,25(5):657-658.[33]Syrimis A,Nicolaou N,Alexandrou A,et al.Molecular analysis of Cypriot families with aniridia reveals a novel PAX6 mutation[J].Mol Med Rep,2018,18(2):1623-1627.[34]Zhang Y,Ding J,Wang S,et al.Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families[J].Eur J Hum Genet,2020,28(2):244-252.[35]耿仁芳,郑洁,周青,等.先天性无虹膜家系致病基因的突变检测[J].安徽医科大学学报,2015,50(9):1312-1315.[36]Lee PC,Lam HH,Ghani SA,et al.Investigation of a PAX6 gene mutation in a Malaysian family with congenital aniridia[J].Genet Mol Res,2014,13(2):3553-3559.[37]Liu Q,Wan W,Liu Y,et al.A novel PAX6 deletion in a Chinese family with congenital aniridia[J].Gene,2015,563(1):41-44.[38]Huang L,Li W,Tang W,et al.A Chinese family with Oguchi’s disease due to compound heterozygosity including a novel deletion in the arrestin gene[J].Mol Vis,2012(18):528-536.[39]董世栖,董素芳,乔晨,等.PAX6基因突变的鉴定与中国家系无虹膜症合并妊娠期糖尿病的产前诊断[J].国际眼科杂志,2019,19(9):1457-1461.[40]肖紫云,邢怡桥.土家族中一个先天性无虹膜家系的临床特点和PAX6基因突变位点分析[J].中华眼视光学与视觉科学杂志,2018,20(2):109-113.[41]Ewans LJ,Schofield D,Shrestha R,et al.Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders[J].Genet Med,2018,20(12):1564-1574.[42]Kaiwar C,Kruisselbrink TM,Kudva YC,et al.Exome sequencing confirms diagnosis of kabuki syndrome in an-adult with hodgkin lymphoma and unusually severe multisystem phenotype[J].Clin Immunol,2019(207):55-57.[43]Duerinckx S,Jacquemin V,Drunat S,et al.Digenic inheritance of human primary microcephaly delineates centrosomal and non-centrosomal pathways[J].Hum Mutat,2020,41(2):512-524.[44]Fan LL,Liu JS,Huang H,et al.Whole exome sequencing identified a novel mutation (p.Ala1884Pro) of β-spectrin in a Chinese family with hereditary spherocytosis[J].J Gene Med,2019,21(2-3):e3073.[45]Fan KH,Feingold E,Rosenthal SL,et al.Whole-Exome Sequencing Analysis of Alzheimer’s Disease in Non-APOE*4 Carriers[J].J Alzheimers Dis,2020,76(4):1553-1565.

更新日期/Last Update: 1900-01-01